Burn statistics are changing fast, but a few figures already stand out. In 2023, only about 8.7% of U.S. e cigarette users reported non daily use, while the EU put current e cigarette use at 7% of adults, setting up a clear contrast in how people actually use these products. From nicotine salts and PM2.5 particle emissions to quitting outcomes, aerosol chemistry, and even cost and EVALI impact, the dataset connects chemistry at the coil to real world health numbers.
Key Takeaways
- About 8.7% of U.S. adults who used e-cigarettes in 2023 used them on some days (non-daily use share).
- In the EU, 7% of adults reported current use of e-cigarettes in 2023 (reported current use).
- Nicotine is typically delivered in higher concentrations via salt formulations; a study reported that nicotine salts enable nicotine levels of ~20–50 mg/mL in e-liquids while maintaining smoother inhalation.
- A 2019 review found that e-cigarettes can generate fine particulate matter (PM2.5) during use at levels influenced by device power, with reported PM2.5 concentrations ranging broadly across studies.
- The EU Tobacco Products Directive limits nicotine concentration to 20 mg/mL for e-liquids unless exemptions apply.
- A 2022 peer-reviewed study measured that aerosol pH from e-cigarettes can increase rapidly upon mixing, affecting nicotine protonation and delivery.
- In controlled testing, device power (wattage) has been shown to substantially affect aerosol emissions; a lab study reported higher power increases aerosol mass and nicotine delivery compared with lower power settings.
- A study found that average nicotine yield from e-cigarette aerosol measured by trapping/analysis ranged from 0.5 mg to 2.0 mg per 10 puffs depending on device parameters.
- The WHO estimates that over 1 billion people are using tobacco products worldwide; e-cigarettes are one of the rapidly emerging nicotine delivery products monitored under tobacco control.
- A 2018 study estimated that if e-cigarettes are widely adopted by smokers as substitutes, the potential public health benefits could be substantial in the U.K., measured as thousands of life-years gained in modeling scenarios.
- A 2020 peer-reviewed economic evaluation reported that nicotine e-cigarettes are often cost-effective for smoking cessation compared with licensed nicotine replacement therapy under common willingness-to-pay thresholds.
- The global e-cigarette liquid (e-liquid) market was projected to reach $15.0 billion by 2030
Non daily vaping affects millions, but nicotine salts and emissions dynamics shape dependence risk and cessation potential.
Related reading
01 · Category
User Adoption2 stats
01
About 8.7% of U.S. adults who used e-cigarettes in 2023 used them on some days (non-daily use share).
02
In the EU, 7% of adults reported current use of e-cigarettes in 2023 (reported current use).
Interpretation
User Adoption Interpretation
From a user adoption perspective, e-cigarette use extends beyond daily habits, with 8.7% of U.S. adult users reporting non-daily use in 2023 and 7% of EU adults reporting current use that same year.
02 · Category
Industry Trends6 stats
01
Nicotine is typically delivered in higher concentrations via salt formulations; a study reported that nicotine salts enable nicotine levels of ~20–50 mg/mL in e-liquids while maintaining smoother inhalation.
02
A 2019 review found that e-cigarettes can generate fine particulate matter (PM2.5) during use at levels influenced by device power, with reported PM2.5 concentrations ranging broadly across studies.
03
The EU Tobacco Products Directive limits nicotine concentration to 20 mg/mL for e-liquids unless exemptions apply.
04
A 2023 Cochrane review found that nicotine e-cigarettes may increase quit rates compared with nicotine replacement therapy, with evidence certainty varying by outcome.
05
A 2021 systematic review reported that adult smokers switching to e-cigarettes had reduced cigarette consumption by a median of about 50% across studies.
06
The 2019–2020 EVALI outbreak resulted in 68 deaths in the U.S. (cumulative through the CDC’s EVALI reporting).
Interpretation
Industry Trends Interpretation
Industry trends show e-cigarette nicotine and use patterns are being shaped by regulation and evidence, with nicotine salts supporting about 20 to 50 mg/mL e-liquids where allowed while quit and switching outcomes continue to improve, such as a median 50% reduction in cigarettes for adults and e-cigarettes potentially boosting quit rates over NRT in a 2023 Cochrane review.
03 · Category
Performance Metrics10 stats
01
A 2022 peer-reviewed study measured that aerosol pH from e-cigarettes can increase rapidly upon mixing, affecting nicotine protonation and delivery.
02
In controlled testing, device power (wattage) has been shown to substantially affect aerosol emissions; a lab study reported higher power increases aerosol mass and nicotine delivery compared with lower power settings.
03
A study found that average nicotine yield from e-cigarette aerosol measured by trapping/analysis ranged from 0.5 mg to 2.0 mg per 10 puffs depending on device parameters.
04
The US Surgeon General concluded in 2016 that nicotine exposure from e-cigarettes is sufficient to create dependence in youth and young adults.
05
A 2022 analysis reported that e-cigarette aerosol can contain volatile organic compounds (VOCs), including formaldehyde and acetaldehyde, with measured levels dependent on voltage, coil material, and puff topography.
06
In a 2018 study, e-cigarettes using certain coil temperatures produced higher levels of aldehydes than lower-temperature devices under standardized puffing.
07
A 2020 laboratory study reported that aerosol particle size distribution from e-cigarettes includes a significant fraction in the submicron range (e.g., ~100–300 nm), supporting deep lung deposition potential.
08
In a 2019 peer-reviewed study, e-cigarette emissions included ultrafine particles; measured concentrations were often in the 10^5–10^7 particles/cm^3 range during active vaping sessions.
09
A 2021 clinical study found that switching from smoking to e-cigarettes led to a reduction in exhaled carbon monoxide levels compared with continued smoking (mean CO reduction measured).
10
In a 2017 randomized trial, participants using nicotine e-cigarettes had improved abstinence rates versus placebo for short-term follow-up, with abstinence defined by biochemical verification.
Interpretation
Performance Metrics Interpretation
Performance-related device settings drive measurable changes in e-cigarette delivery, with studies showing aerosol nicotine yield ranges from about 0.5 mg to 2.0 mg per 10 puffs and emissions shifting toward more submicron and ultrafine particle fractions, underscoring how wattage, voltage, coil temperature, and puff topography can substantially alter performance metrics.
More related reading
04 · Category
Cost Analysis7 stats
01
The WHO estimates that over 1 billion people are using tobacco products worldwide; e-cigarettes are one of the rapidly emerging nicotine delivery products monitored under tobacco control.
02
A 2018 study estimated that if e-cigarettes are widely adopted by smokers as substitutes, the potential public health benefits could be substantial in the U.K., measured as thousands of life-years gained in modeling scenarios.
03
A 2020 peer-reviewed economic evaluation reported that nicotine e-cigarettes are often cost-effective for smoking cessation compared with licensed nicotine replacement therapy under common willingness-to-pay thresholds.
04
A 2014 randomized controlled trial found that using e-cigarettes for smoking cessation increased quit attempts relative to nicotine patches, with cost-effectiveness assessed at follow-up (modeled cost per quitter).
05
U.S. poison center costs: poison centers report thousands of nicotine exposure calls annually related to e-cigarettes; these calls contribute to total public health response costs estimated in national poison surveillance.
06
A 2023 study in the Journal of Addiction Medicine reported that health system costs attributable to vaping-associated acute events can be non-trivial, with costs driven by emergency department and inpatient utilization (measured average cost per encounter).
07
A 2020 cost-effectiveness analysis estimated that nicotine e-cigarettes cost about $6,000per additional quitter compared with nicotine replacement therapy (base case)
Interpretation
Cost Analysis Interpretation
Cost analysis shows that while modeling studies in the U.K. suggest e-cigarettes could generate thousands of life-years gained and multiple economic evaluations find them often cost-effective, U.S. poison center and healthcare system expenses also matter, including a 2020 estimate of about $6,000 per additional quitter versus nicotine replacement therapy and 2023 findings that vaping-related acute events can create non-trivial costs driven by emergency and inpatient care.
05 · Category
Market Size1 stats
01
The global e-cigarette liquid (e-liquid) market was projected to reach $15.0 billion by 2030
Interpretation
Market Size Interpretation
From a Market Size perspective, the global e cigarette liquid market is set to climb to $15.0 billion by 2030, signaling strong long term growth.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Karl Becker. (2026, February 13). Burn Statistics. Gitnux. https://gitnux.org/burn-statistics
MLA
Karl Becker. "Burn Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/burn-statistics.
Chicago
Karl Becker. 2026. "Burn Statistics." Gitnux. https://gitnux.org/burn-statistics.
Sources & references
26 datasets cited across this report · attribution is report-level
+16 additional datasets cited (not shown individually)